No spam - just the good stuff

Subscribe to our newsletter
Hidden
  • News
  • Investor Portal
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

InvestmentInvestor Portal

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
Posted on October 26, 2022November 29, 2022

Kizoo invests in rejuvenation startup Mogling Bio

MoglingBio closes seed investment round with Kizoo Technology Capital. MoglingBio, a privately held biotech company, has announced today that it …

Continue reading “Kizoo invests in rejuvenation startup Mogling Bio”

Posted on April 7, 2022May 9, 2022

Kizoo portfolio company Elastrin Therapeutics closes $10 million funding round

Funding used to accelerate vascular treatment development ahead of next year’s clinical trials in humans. Elastrin Therapeutics, a privately held …

Continue reading “Kizoo portfolio company Elastrin Therapeutics closes $10 million funding round”

Posted on March 4, 2021October 26, 2022

Elastrin limbers up for success with Kizoo funding boost

Kizoo provides seed funding for Elastrin Therapeutics to develop ground-breaking new technology capable of reversing tissue and organ calcification. It …

Continue reading “Elastrin limbers up for success with Kizoo funding boost”

Posted on February 7, 2023March 7, 2023

Longevity investment bulletin: Mesoblast, Endogena, NeuroSense and more.

The latest longevity updates from our investment news desk.   Stock markets rallied in the past week, with investors boosted …

Continue reading “Longevity investment bulletin: Mesoblast, Endogena, NeuroSense and more.”

Posted on February 6, 2023February 6, 2023

Cellvie closes $5.5m to accelerate development of Therapeutic Mitochondria Transplantation

Harvard spin-off closes $5.5m of additional funding to accelerate the development of Therapeutic Mitochondria Transplantation as a new treatment modality. …

Continue reading “Cellvie closes $5.5m to accelerate development of Therapeutic Mitochondria Transplantation”

Posted on November 29, 2022November 29, 2022

Is aging a question of order vs disorder?

Mogling Bio is rejuvenating older stem cells to target age-related disease and restore the function of the aging immune system. …

Continue reading “Is aging a question of order vs disorder?”

Posted on November 10, 2022November 17, 2022

The lifespan revolution is upon us – get involved and get ahead

Be involved and invested in the greatest investment opportunity of all time – longevity. November heralds mists, mellow fruitfulness… and …

Continue reading “The lifespan revolution is upon us – get involved and get ahead”

Posted on September 16, 2022September 16, 2022

Rejuvenation Startup Summit 2022 announces programme and speakers

Forever Healthy Foundation confirms the 2022 programme and full speaker list for Berlin event. The Forever Healthy Foundation has announced …

Continue reading “Rejuvenation Startup Summit 2022 announces programme and speakers”

Posted on September 14, 2022September 14, 2022

Cellvie – unlocking the power of cell-derived medicines

The biotech platform that is leveraging one of the cornerstones of evolution – mitochondria. Mitochondria play a crucial role in …

Continue reading “Cellvie – unlocking the power of cell-derived medicines”

Posts navigation

Page 1 Page 2 Page 3 Next page

Find us here ...

Subscribe to our newsletter

Hidden

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS
The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.